MoneyWorks4Me

Alembic Pharmaceuticals informs about company updates

21 Jan 2020 Evaluate

Alembic Pharmaceuticals has informed that the US Food and Drug Administration (USFDA) has conducted an inspection at the company’s API Facility located at Karkhadi from 13th January, 2020 to 17th January, 2020. This was a scheduled pre-approval inspection and at the end of the inspection, the USFDA issued a Form 483 with two observations. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..